AI assistant
Novonesis AS — Director's Dealing 2008
Sep 18, 2008
3377_rpt_2008-09-18_7b4a0a35-f858-4a7c-b92b-de1da3654a93.pdf
Director's Dealing
Open in viewerOpens in your device viewer
TRADING BY MANAGEMENT IN NOVOZYMES A/S B SHARES
September 18, 2008
In accordance with Section 28a of the Danish Securities Trading Act, Novozymes reports the following transactions under ISIN DK0010272129, Novozymes B shares under the symbol NZYM B.
| Name | Relation/ Category of close relation |
Trading date | Character of the transaction |
No. of shares traded Buy (+) / Sell (-) |
Market value of shares traded (DKK) |
|---|---|---|---|---|---|
| Peder Holk Nielsen |
EVP, Enzymes Business |
18/9 2008 | Share options | - 10,200 | 4,980,550 |
Contact persons:
Press and media: Investor relations:
Johan Melchior Tel. (direct): +45 4446 0690 Tel. (mobile): +45 3077 0690
Paige Donnelly (USA) Tel. (direct): +1 919 494 3209 Tel. (mobile): +1 919 218 4501
Camilla Kinch Jensen Tel. (direct): +45 4446 0852 Tel. (mobile): +45 3077 0852
Tobias Bjørklund (USA) Tel. (direct): +1 919 494 3483 Tel. (mobile): +1 919 649 2565
Novozymes is the world leader in bioinnovation. Together with customers across a broad array of industries we create tomorrow's industrial biosolutions, improving our customers' business and the use of our planet's resources. Read more at www.novozymes.com.
Company announcement no. 10, 2008 Page 1 of 1 Novozymes A/S Investor Relations
Krogshøjvej 36 2880 Bagsværd Denmark
Telephone: +45 4446 0000 Fax: +45 4446 1002
Internet: www.novozymes.com CVR number: 10 00 71 27